
Jeffrey Tepper, PhD, DABT, DSP
Inhalation Toxicology Consultant
Toxicology Drug Development Consultant
- More than 35 years’ experience, with over ten years’ as a preclinical research and development consultant
- Board certification in toxicology and safety pharmacology
- Successful track record of transitioning early drug concepts from animal pharmacology through GLP toxicology and into clinical studies
- Skills honed as a Senior Scientist at Genentech, Director of Pharmacology at Bayer Biotechnology, VP of Pharmacology/Toxicology at Catalyst Biosciences and as a Co-Founder and Senior Director Pharmacology/Toxicology of Aerovance Inc., a respiratory-focused biotech company
Specialties:
- Nonclinical drug development• Inhalation toxicology and respiratory pharmacology
- Inflammatory, cardiovascular, gastrointestinal, ophthalmology and arthropathy indications• Inhalation, intranasal, intra-articular and intravitreal administration
- Recombinant and engineered proteins, oligonucleotides, antibodies, peptides, small molecules, PEGylated molecules and drug-device combinations